Moody Aldrich Partners LLC Paratek Pharmaceuticals, Inc. Transaction History

Moody Aldrich Partners LLC

  • $503 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 26, 2018
SELL
$12.65 - $18.85 $688,084 - $1.03 Million
-54,394 Closed
0 $0
Q4 2017

Jan 31, 2018
BUY
$17.45 - $25.6 $197,603 - $289,894
11,324 Added 26.29%
54,394 $974,000
Q3 2017

Nov 13, 2017
BUY
$18.9 - $28.2 $814,022 - $1.21 Million
43,070
43,070 $1.08 Million

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email